Global EditionASIA 中文雙語(yǔ)Fran?ais
Business
Home / Business / Industries

Pharmaceutical companies grab Chinese market opportunities

By LIU ZHIHUA | China Daily | Updated: 2023-02-03 09:11
Share
Share - WeChat
Visitors gather at Danish pharmaceutical company Novo Nordisk's booth during the fifth China International Import Expo in Shanghai in November. [PHOTO by ZHU XINGXIN/CHINA DAILY]

MNCs share confidence to invest, expand with nation's high-standard opening-up

As the first multinational healthcare company to settle in the Lingang Special Area of the China (Shanghai) Pilot Free Trade Zone, Danish pharmaceutical company Novo Nordisk announced at the end of last year that it would invest 400 million yuan ($59.6 million) in a newly established company in the area.

With that investment, the company will upgrade its whole industrial layout in China to better seize the opportunities of China's high-quality development, said Zhou Xiaping, global senior vice-president of Novo Nordisk and president of Novo Nordisk China.

That's just one example from the past year of foreign pharmaceutical enterprises casting a vote of confidence in China's market to expand their investments, eyeing brightening prospects.

China, the world's second-largest economy and pharmaceutical market, only after the United States, has been playing an increasingly growing role in the global pharmaceutical market, both as a consumer country and as a crucial link in the global pharmaceutical industrial and supply chains.

The annual tone-setting Central Economic Work Conference, held in December, said China will make greater efforts to attract and utilize foreign capital, widen market access, promote the opening-up of modern service industries and grant foreign-funded enterprises national treatment.

The innovation and creativity potential of the whole society should be unleashed to the greatest extent, while the potential of the domestic market will also be fully tapped so that domestic demand can play a stronger role in driving economic growth, according to the meeting.

Experts and business leaders said China's unwavering commitment to deepening reform and expanding high-level opening-up, its stress on innovation and technological advancement, and the fast-growing pharmaceutical market in China due to the large population's increasing awareness and spending on healthcare products and services, will jointly shore up foreign investment into its pharmaceutical industry despite challenges and complexities from the external environment.

They also said sectors such as biomedicine, vaccines, antivirus solutions, and in particular, rare diseases and chronic disease treatments, have especially huge growth potential.

Seeing the China market potential and impressed by China's resolve to expand high-level opening-up, Japanese pharmaceutical company Astellas has set a strategic focus on breakthroughs in oncology and innovative drugs and therapies in China.

Currently, it is accelerating the introduction of innovative drugs to China and enhancing accessibility, which include a first-in-class antibody conjugate drug.

"China has always been a vital market for Astellas' global growth and it has now risen to the top tier of Astellas' global strategic markets based on its strong performance and significance," said Hiroshi Hamaguchi, chairman and president of Astellas China.

"As the world's second-largest pharmaceutical market, China presents us with great development potential with tremendous unmet medical needs ... we will continue to leverage China's favorable policies, and work with the government and all business partners to actively explore every possibility of (drug registration) acceleration," he said.

Huang Feng, chairman of the Shanghai Foreign Investment Association, said foreign investors and multinational companies have advanced research and development technology and experience to meet China's huge market demand, which will ensure promising growth prospects of foreign investment into China's pharmaceutical industry.

In particular, the country's newest catalog of industries for attracting foreign investment, which took effect on Jan 1, continues to encourage foreign investment in the manufacturing industry and has shed a spotlight on sectors including rare disease drugs, children's medicines and high-end medical devices, he said.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 亚洲国产精品无码久久青草| 激情影院在线观看十分钟| 精品国产亚洲一区二区三区在线观看 | 久久天天躁狠狠躁夜夜躁综合| 中文字幕日韩高清| aaaaa级少妇高潮大片| 国产在线播放你懂的| 精品国产v无码大片在线看| 欧美日韩在线观看免费| 无码欧精品亚洲日韩一区| 性高朝久久久久久久| 国产麻豆一精品一aV一免费| 国产三香港三韩国三级不卡| 亚洲欧美精品日韩欧美| 久久99精品久久久久麻豆| 69久久夜色精品国产69小说| 美国一级毛片免费视频观看| 欧美国产伦久久久久| 成人午夜精品无码区久久| 国产福利一区二区精品秒拍| 六月丁香婷婷色狠狠久久| 久久精品国产一区二区三区 | 国产极品美女到高潮| 八木梓纱老师三天两夜| 五月天婷婷精品视频| eeuss影院机在线播放| 草莓视频在线免费| 欧洲精品无码一区二区三区在线播放| 婷婷啪啪婷婷啪啪| 国产交换配乱婬视频| 亚洲国产精品综合久久2007| ssni-436| 老妇高潮潮喷到猛进猛出| 最刺激黄a大片免费观看下截| 国内精品久久久久影院一蜜桃| 同桌好舒服好粗好硬| 久久综合网欧美色妞网| 18pao国产成视频永久免费| 玩弄CHINESE丰满人妻VIDEOS| 成年人视频免费在线观看| 国产成人涩涩涩视频在线观看|